MSU professor to lead acetazolamide clinical trial on idiopathic intracranial hypertension
A rare but increasingly more common disease striking overweight, younger women is the focus of a clinical trial at Michigan State University, where an osteopathic physician is testing the effectiveness of a certain drug against a potentially blindness-causing ailment.